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An autosomal recessive syndrome of nonprogressive cerebellar ataxia and mental retardation is associated with
inferior cerebellar hypoplasia and mild cerebral gyral simplification in the Hutterite population. An identity-by-
descent mapping approach using eight patients from three interrelated Hutterite families localized the gene for this
syndrome to chromosome region 9p24. Haplotype analysis identified familial and ancestral recombination events
and refined the minimal region to a 2-Mb interval between markers D9S129 and D9S1871. A 199-kb homozygous
deletion encompassing the entire very low density lipoprotein receptor (VLDLR) gene was present in all affected
individuals. VLDLR is part of the reelin signaling pathway, which guides neuroblast migration in the cerebral cortex
and cerebellum. To our knowledge, this syndrome represents the first human lipoprotein receptor malformation
syndrome and the second human disease associated with a reelin pathway defect.
An autosomal recessive syndrome of nonprogressive cere-
bellar ataxia, mental retardation, and cerebellar hypo-
plasia was recognized and described in the Hutterite
population in the 1980s (Schurig et al. 1981; Pallister
and Opitz 1986). This constellation of findings was re-
ferred to as “dysequilibrium syndrome” (DES [MIM
224050]) on the basis of the clinical similarity to a group
of patients with syndromic nonprogressive cerebellar
ataxia initially described by Hagberg et al. in 1972 (Hag-
berg et al. 1972). As part of a larger project to char-
acterize cerebellar disorders in the Hutterite population,
we identified 12 Hutterites with DES (hereafter, “DES-
H” refers to DES in the Hutterite population) and fur-
ther described the clinical and neuroimaging features
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(Glass et al., in press). DES-H is a nonprogressive syn-
drome characterized by moderate-to-profound mental re-
tardation, delayed ambulation, and predominantly trun-
cal ataxia. Additional features include strabismus and pes
planus in the majority of patients, seizures in 40% of
patients, and short stature in 15% of patients. Magnetic
resonance imaging (MRI) demonstrates inferior cerebellar
hypoplasia and mild cortical gyral simplification (fig. 1).
The Hutterites originated from one of several Anabap-
tist groups formed during the Protestant Reformation in
the 16th century and have lived on the North American
prairies since the late 1800s (Hostetler 1985). The popula-
tion now numbers 140,000 individuals, the majority of
whom are descendants of 89 founders (Nimgaonkar et
al. 2000). The unique social characteristics of this popu-
lation have resulted in virtual genetic isolation. In a re-
constructed 1981 census of 25,223 Hutterites in North
America, the average inbreeding coefficient was 0.038,
with a range of 0–0.164 (T. M. Fujiwara and K. Morgan,
unpublished data). Over 30 different autosomal recessive
conditions have been described in the Hutterite popula-
tion (Innes et al. 1999). Given the population’s charac-
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Figure 1 MRI demonstrating characteristic brain malformations seen in patients with DES-H. A, Sagittal T1W. B, Axial T1W. C, Coronal
T2W spin echo images showing a small cerebellum in a fluid-filled but normal-sized posterior fossa. The superior half of the vermis is formed,
but the inferior half is not. The pons is abnormally small. The cerebral cortex is simplified. Reprinted with permission (Glass et al., in press).
teristics, it is likely that each of these rare alleles was
introduced by a single ancestor.
We used an identity-by-descent mapping approach to
localize the gene for DES-H to chromosome region 9p24.
DNA samples from the eight patients of families 1, 2, and
3 (fig. 2) were genotyped using a set of 400 polymorphic
microsatellite markers (ABI PRISM Linkage Mapping Set
version 2 [Applied Biosystems]) with an average spacing
of !10 cM and heterozygosity of 0.79. The amplified
PCR products were analyzed on an ABI 377 automated
sequencer (Applied Biosystems), and the data were pro-
cessed using GeneScan (version 3.7) and Genotyper (ver-
sion 3.7) software (Applied Biosystems). Data from the
genome scan identified homozygosity in at least five of
the eight initial patients, with allele sharing in the re-
maining patients, for eight different loci. For these can-
didate regions, DNA from the eight patients and their
family members (parents and unaffected siblings) was
genotyped using the marker of interest as well as ad-
ditional flanking microsatellite markers from the 5-cM
Linkage Mapping Set (ABI PRISM Linkage Mapping Set
version 2) and/or from the Ge´ne´thon, deCode, or Marsh-
field maps (Human Genome Resources Web site). Hap-
lotype construction by visual inspection within the nu-
clear families allowed seven of these regions to be ex-
cluded on the basis of lack of segregation of the haplo-
type with the disorder.
A three-marker haplotype generated using the ge-
nome scan marker D9S288 and two flanking markers,
D9S1858 (distal) and D9S1810 (proximal), from the
telomeric region of the p arm of chromosome 9 segre-
gated with DES-H in the families, and seven of the initial
eight patients were homozygous for the shared haplo-
type. Additional markers were genotyped in the region
for these eight patients, as well as for two additional
patients from family 4 and parents and unaffected sib-
lings from all families. Multipoint linkage calculations
(Kruglyak et al. 1996; University of Pittsburgh Depart-
ment of Human Genetics Web site) between DES-H and
the markers indicated in figure 2 revealed a LOD score
14.0 for 11 markers from D9S917 to D9S1810, with a
maximum of 4.3, providing statistical evidence of link-
age to the telomeric end of the short arm of chromosome
9, in region 9p24. This analysis was performed under
the assumption of autosomal recessive inheritance with
complete penetrance. Marker-allele frequencies were es-
timated from the observed alleles in all the genotyped
individuals. Although the families were known to be
related in multiple different ways (Glass et al., in press),
the four pedigrees shown in figure 2 were used to cal-
culate linkage, since they were expected to provide suf-
ficient power. The frequency of the DES-H allele was set
at 0.03333, on the basis of an observed population fre-
quency of 1/900 (Glass et al., in press) and under the
assumption of Hardy-Weinberg equilibrium. This is
probably an overestimate of the true DES-H allele fre-
quency, given the level of inbreeding in the Hutterites.
The extended haplotypes demonstrated both familial
and ancestral recombination events (fig. 2). On the basis
of familial recombination events, the minimal region for
the DES-H locus was 18.1 cM (11.0 and 25.6 cM on the
female and male, respectively, Marshfield genetic maps),
between the p telomere and D9S286. Under the assump-
tion of identity by descent and inferred ancestral recom-
bination, the DES-H locus was predicted to lie in a 5.5-
cM interval between D9S129 and D9S1871 (genetic dis-
tance estimated from the physical map for D9S129 and
from the Marshfield genetic map and the physical map
for D9S1871), in which all patients were homozygous
for the same allele at D9S143, D9S54, D9S228, and
Figure 2 Haplotype analysis of the Hutterite families. Affected individuals are identified by blackened symbols and unaffected family
members by unblackened symbols. In family 1, individuals I-2 and I-3 are full siblings. Haplotypes were constructed by visual inspection, with
the assumption of a minimal number of recombination events. The marker order was determined from the physical map of the region. For the
children in each family, the allele on the left was inherited from the father and the allele on the right from the mother. A patterned bar indicates
haplotypes for chromosome 9 markers, a black bar indicates the alleles associated with the DES-H disease allele, and a gray region indicates
a region in which a recombinant event occurred. An observed paternal recombination event in unaffected sibling II-3 from family 4 indicates
a proximal limit of D9S286 for the DES-H locus. A recombinant defining the distal boundary for the DES-H locus was not identified. The
boxed markers correspond to the smallest region of shared homozygosity and the minimal region for the DES-H gene. D9S129 was predicted
to be the distal limit, on the basis of inferred ancestral recombination events that resulted in different D9S129 alleles in affected individuals II-1
from family 2 and the siblings II-1 and II-2 from family 4. D9S1871 was predicted to be the proximal limit on the basis of an inferred recombinant
in one of the ancestors of the father in family 2, who carried a different allele on the disease chromosome at this locus.
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Figure 3 Characterization of the VLDLR deletion. A, STS walking strategy used to identify the deletion boundaries. STSs were scored
as “present” or “absent” in the genomic DNA of patients with DES-H. The dashed line represents the deletion. Blackened circles indicate that
STSs are present, and unblackened circles indicate that STSs are not present in patient genomic DNA. The distal boundary was narrowed to
a 69-kb region 130 kb from VLDLR by use of STSs present in UniSTS; the proximal boundary was estimated to be within the 70-kb region
between VLDLR and KCNV2, on the basis of the presence of exon 1 of the KCNV2 gene in genomic DNA of patients, by use of PCR
amplification. STSs were then generated using the chromosome 9 genomic contig (GenBank accession number NT_008413) at 10-kb intervals,
to walk along the chromosome in both the 69-kb distal and 70-kb proximal regions. Within these 10-kb intervals, STSs were generated every
1 kb (all primer sequences and amplification conditions available on request). The forward primer of the most-proximal STS present in the
distal boundary and the reverse primer of the most-distal STS present in the proximal boundary in genomic DNA of patients were used to
amplify a 2.6-kb fragment spanning the deletion. Because of the large size of the deletion, these primers could not be used to amplify control
DNA; instead, forward and reverse primers of the two flanking STSs for each of the boundary regions were used. B, Sequence of deletion
boundaries. The products a, b, and c were sequenced using the ABI PRISM BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems)
and an ABI PRISM 377 automated sequencer. A direct 8-bp repeat (underlined) was present in the sequenced junction fragment of a patient
with DES-H (b) and in the 5′ and 3′ flanking sequences of control DNA (a and c). C, Segregation analysis. Genomic DNA from patients and
family members was amplified using a three-primer reaction mix, which generated a 784-bp fragment from a normal chromosome and a 440-
bp fragment from a chromosome with the VLDLR deletion. Affected individuals are identified by blackened symbols, unaffected family members
by unblackened symbols, and carriers by a small blackened circle within the symbol. The 440-bp product was identified in the patients with
DES-H, the 784-bp and 440-bp products in carriers, and the 784-bp product in noncarriers. D, Map of the deleted region. The deleted segment
was 199 kb in size and contained the entire VLDLR gene and part of LOC401491. KCNV2, which is proximal to VLDLR, was not contained
within the deletion.
D9S939. The 5.5-cM DES-H candidate region between
D9S129 and D9S1871 corresponded to a 2-Mb interval
and contained 10 transcripts, of which 6 encoded char-
acterized genes.
The critical interval contained an obvious candidate,
the VLDLR gene, which encodes a receptor for reelin.
The reelin signaling pathway guides neuroblast migra-
tion in the cerebral cortex and cerebellum (D’Arcangelo
et al. 1995; Rice and Curran 2001; Tissir and Goffinet
2003). VLDLR consists of 19 exons and spans ∼40 kb
(Sakai et al. 1994). Attempts to amplify the VLDLR
coding exons by PCR repeatedly failed in patients but
not in controls or unaffected family members. Lack of
amplification of exons 1A and 19 suggested a homo-
zygous deletion of the entire VLDLR coding region (data
not shown). Part of exon 1 of the KCNV2 gene (Gen-
Bank accession number AL354723), ∼70 kb proximal to
VLDLR, was present in patients, as determined by PCR
amplification. Exon 4 of the SMARCA2 gene (GenBank
accession number AL138755), 430 kb distal to VLDLR,
was identified in patients by PCR amplification of the
trinucleotide repeat PMC303366P11 (UniSTS) (data not
shown). These results were consistent with a deletion of
!500 kb.
To determine the extent of the deleted sequence en-
compassing VLDLR, we used a sequence-tagged site
(STS) walking strategy (fig. 3A). This approach gener-
ated a 2.6-kb junction fragment, which was amplified
and sequenced in patients with DES-H and was com-
pared with sequences generated by amplifying the two
STSs flanking the proximal and distal boundaries in con-
trol DNA (fig. 3B). A homozygous deletion of 199,163
bp was present in each patient. A three-primer reaction
was designed to allow for coamplification of both the
normal and deleted alleles. Genomic DNA from all pa-
tients, parents, and siblings was amplified, and results
were consistent with the linkage and haplotype data;
each parent was a carrier of the deletion (fig. 3C). An
8-bp direct repeat, GAAAACAA (fig. 3B), was present
at the breakpoints. Such short direct repeats have been
found to mark the endpoints of many pathogenic de-
letions, which suggests that the repeats predispose to
slippage during DNA replication that results in deletion
of the intervening sequence and one of the repeat se-
quences (Antonarakis et al. 2001).
The 199-kb deletion contained the entire VLDLR gene
and part of a hypothetical gene, LOC401491 (GenBank
[accession number AK092343]) (fig. 3D). The latter gene
is supported by the presence of a 3,167-bp transcript,
which is widely expressed and is predicted to encode a
109-aa protein. The entire coding region of this gene
falls within the DES-H deletion. The sequence shows 80%
homology to the ALU6 human Alu subfamily. Given the
extent of the deletion, it is also possible that the ex-
pression of flanking genes is also affected because of the
absence of intergenic regulatory elements. Comparison
of the clinical findings of the patients with DES-H with
the Vldlr-deficient mouse model (see below) supports
homozygous loss of VLDLR as the major contributor
to the DES-H phenotype.
VLDLR is part of the reelin signaling pathway, which
guides neuroblast migration in the developing cerebral
cortex and cerebellum (D’Arcangelo et al. 1995; Rice
and Curran 2001; Tissir and Goffinet 2003). In the cor-
tex, Cajal-Retzius cells in the preplate secrete reelin to
guide the cells of the cortical plate. In the cerebellum,
the granule cells secrete reelin, which guides migration
of Purkinje cells. VLDLR and apolipoprotein E receptor
type 2 (ApoER2) are transmembrane receptors for reelin.
With reelin binding, the cytoplasmic adaptor protein dis-
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abled-1 (Dab1) docks to the NPxY sequence in the in-
tracellular region of VLDLR and ApoER2 and becomes
phosphorylated (Howell et al. 1997; Trommsdorff et al.
1999), which triggers an intracellular signaling cascade
that allows neuroblasts to complete migration and adopt
their ultimate positions in laminar structures in the CNS.
Much of what is known about the reelin pathway
comes from the study of a number of mouse models (re-
viewed by Lambert de Rouvroit and Goffinet [1998] and
Tissir and Goffinet [2003]). In mice, deficiency of reelin
results in the reeler phenotype (D’Arcangelo et al. 1995),
which is characterized by impaired motor coordination,
tremors, and ataxia. Reeler-like mice result from mu-
tations in Dab1 (Howell et al. 1997) and double mu-
tations in the lipoprotein receptors, Vldlr and ApoER2
(Trommsdorff et al. 1999). In reeler and reeler-like mice,
the preplate forms normally, with migration of cortical
neurons from the germinative zones. However, as the
neurons approach their destination, they fail to recog-
nize their proper location and orientation. Later-migrating
neurons fail to split the preplate into the marginal zone
and subplate and instead form layers below the preplate
with a reverse “outside-in” pattern compared with nor-
mal cortex. Reelin is also involved in the radial glial
scaffold in the hippocampus. In reeler mutants, the
distinct “reeling” gait is caused by profound hypoplasia
of the cerebellum, in which the normal cerebellar folia
are missing. Vldlr knockout mice with intact ApoER2
appear neurologically normal (Frykman et al. 1995).
However, the Vldlr-deficient mouse cerebellum is small,
with reduced foliation and heterotopic Purkinje cells
(Trommsdorff et al. 1999). Neurons in the Vldlr-de-
ficient murine cortex fail to distribute normally after
reaching their assigned layer. The clinical and pathologi-
cal features of the Vldlr-deficient mouse are less severe
than those seen in the reeler mouse.
Like reeler, mutations in the human orthologue reelin
(RELN) cause significant disruption of neuroblast mi-
gration and architecture in the cerebellum and cerebral
cortex. A syndrome of autosomal recessive lissencephaly
with cerebellar hypoplasia (LCH) has been shown to be
caused by mutations in RELN in two families (Hong et
al. 2000). The phenotype in these patients was charac-
terized by hypotonia, ataxia, and developmental delay,
with lack of unsupported sitting and profound mental
retardation with little or no language development. Sei-
zures and congenital lymphedema were also present. In
contrast, patients with DES-H have moderate motor
delays, with most eventually walking unsupported, and
predominantly moderate-to-severe mental retardation
(Schurig et al. 1981; Glass et al., in press). Neuroimaging
of patients with a RELN mutation demonstrated mod-
erate lissencephaly, with an anterior greater than pos-
terior gradient, a malformed hippocampus, and pro-
found cerebellar hypoplasia with complete absence of
detectable cerebellar folia (Hong et al. 2000). In DES-
H, the primary abnormality found on neuroimaging was
marked hypoplasia of the cerebellar hemispheres and
inferior vermis (fig. 1). A simplification and thickening
of the cerebral cortex was also present, but this was a
much milder feature in comparison with that of patients
with a RELN mutation. In DES-H, the hippocampi ap-
peared to undergo normal developmental rotation com-
pared with the fetal configuration of the hippocampi
in the patients with a RELN mutation. Deficiency of
VLDLR in both mice and humans is associated with a
less-severe phenotype than that seen with deficiency of
reelin.
Six subtypes of LCH have been defined (Ross et al.
2001). In this group of syndromes, the term “lissenceph-
aly” refers to both the classic pattern of pachygyria/
agyria, with marked thickening of the gray matter, and
to less-severe phenotypes, ranging from mild pachygyria
to simplification of the cortical gyral pattern with near-
normal gray-matter thickness. Cerebellar manifestations
range from relatively preserved hemispheres to marked
cerebellar hypoplasia with foliation defects. The human
phenotype associated with mutations in RELN has been
classified as “LCHb” (Ross et al. 2001). The malforma-
tions seen in DES-H also fall within the LCH spectrum,
with mild cerebral gyral simplification and more-marked
cerebellar hypoplasia.
VLDLR also functions as a peripheral lipoprotein
receptor for VLDL triglycerides in mice. The low den-
sity lipoprotein receptor (LDLR) can mask the effect of
VLDLR on lipoprotein metabolism (Tacken et al. 2000;
reviewed by Takahashi et al. [2004]). Vldlr-deficient mice
are protected from obesity after exposure to a high-fat,
high-calorie (HFC) diet and have increased plasma tri-
glycerides after HFC feeding (Goudriaan et al. 2001). Of
the patients with DES-H, 50% had a BMI !18.5 (under-
weight), which suggests that there may be some protection
from obesity.
In summary, a homozygous deletion of the very low
density lipoprotein receptor causes an autosomal reces-
sive syndrome of cerebellar hypoplasia in the Hutterite
population. We propose that this condition now be re-
ferred to as “VLDLR-associated cerebellar hypoplasia”
(VLDLR-CH) to recognize the molecular pathogenesis.
To our knowledge, this condition represents the first hu-
man lipoprotein receptor malformation syndrome and
the second human disease associated with a reelin path-
way defect. The clinical manifestations and MRI findings
observed in this group of patients provide insight into
the effects of homozygous loss of VLDLR on the devel-
opment of the human CNS. It will be important to de-
termine whether mutations in VLDLR and/or other genes
in the reelin pathway cause cerebellar hypoplasia in pa-
tients from other populations.
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